Skip to Content

Goldman Sachs Focused Value A GFVAX

Medalist Rating as of | See Goldman Sachs Investment Hub
  • NAV / 1-Day Return 15.15  /  −0.07 %
  • Total Assets 49.5 Mil
  • Adj. Expense Ratio
    1.020%
  • Expense Ratio 1.020%
  • Distribution Fee Level Average
  • Share Class Type Front Load
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 1.13%
  • Turnover 82%

USD | NAV as of Apr 24, 2024 | 1-Day Return as of Apr 24, 2024, 11:34 PM GMT+0

Morningstar’s Analysis GFVAX

Will GFVAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Strength in Goldman Sachs Focused Value A's Process Pillar is partially offset by an Average People Pillar rating, leading to a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GFVAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 43.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Exxon Mobil Corp

5.76 3.2 Mil
Energy

Danaher Corp

4.70 2.6 Mil
Healthcare

Colgate-Palmolive Co

4.48 2.5 Mil
Consumer Defensive

Salesforce Inc

4.34 2.4 Mil
Technology

Bank of America Corp

4.31 2.4 Mil
Financial Services

Lowe's Companies Inc

4.15 2.3 Mil
Consumer Cyclical

Bristol-Myers Squibb Co

4.10 2.3 Mil
Healthcare

Zimmer Biomet Holdings Inc

3.96 2.2 Mil
Healthcare

Marvell Technology Inc

3.93 2.2 Mil
Technology

Ameren Corp

3.87 2.1 Mil
Utilities